Pro-forma_JJ Condensed_NNP Combined_NNP Profit_NN and_CC Loss_NN Accounts_NNPS On_IN 15_CD June_NNP 1999_CD ,_, Celltech_NNP and_CC Chiroscience_NNP announced_VBD plans_NNS for_IN the_DT merger_NN of_IN their_PRP$ respective_JJ businesses_NNS ._.
The_DT merger_NN took_VBD effect_NN on_IN 3_CD August_NNP 1999_CD ._.
On_IN 26_CD January_NNP 2000_CD ,_, the_DT Group_NNP acquired_VBD Medeva_NNP PLC._NNP ._.
Due_JJ to_TO the_DT significant_JJ impact_NN to_TO the_DT financial_JJ position_NN of_IN the_DT Group_NNP caused_VBN by_IN these_DT two_CD transactions_NNS ,_, the_DT Directors_NNS believe_VBP that_IN shareholders_NNS would_MD benefit_VB from_IN certain_JJ additional_JJ pro-forma_FW financial_JJ information_NN ._.
Presented_VBN below_IN is_VBZ a_DT five-year_JJ summary_NN of_IN the_DT Celltech_NNP Group_NNP ,_, on_IN a_DT pro-forma_FW basis_NN as_IN if_IN the_DT Chiroscience_NNP and_CC Medeva_NNP businesses_NNS had_VBD been_VBN part_NN of_IN the_DT Celltech_NNP Group_NNP for_IN the_DT entire_JJ period_NN ._.
The_DT results_NNS are_VBP presented_VBN before_IN goodwill_NN and_CC exceptional_JJ items_NNS ._.
The_DT 2002_CD ,_, 2001_CD ,_, 2000_CD and_CC 1999_CD results_NNS are_VBP presented_VBN at_IN historic_JJ exchange_NN rates_NNS ._.
The_DT results_NNS of_IN businesses_NNS which_WDT were_VBD held_VBN for_IN immediate_JJ disposal_NN on_IN the_DT acquisition_NN of_IN Medeva_NNP PLC_NNP and_CC OGS_NNP are_VBP excluded_VBN ._.
The_DT 2003_CD ,_, 2002_CD and_CC 2001_CD figures_NNS are_VBP extracted_VBN ,_, without_IN adjustment_NN ,_, from_IN the_DT audited_JJ profit_NN and_CC loss_NN account_NN ,_, before_IN goodwill_NN and_CC exceptional_JJ items_NNS presented_VBN in_IN the_DT relevant_JJ financial_JJ statements_NNS ._.
The_DT 2000_CD and_CC 1999_CD figures_NNS are_VBP extracted_VBN from_IN the_DT pro-forma_FW note_NN ,_, audited_VBN by_IN Ernst_NNP &_CC Young_NNP and_CC presented_VBN in_IN the_DT 2000_CD financial_JJ statements_NNS ._.
